68 related articles for article (PubMed ID: 3314670)
41. Enhanced invasiveness and metastatic potential of epithelial cell lines cultured in the presence of dimethyl sulphoxide.
Bentel JM; Rhodes GC; Markus I; Smith GJ
Int J Cancer; 1990 Aug; 46(2):251-7. PubMed ID: 2384274
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of metastases by a serum factor associated to concomitant resistance induced by unrelated murine tumors.
Di Gianni P; Franco M; Meiss RP; Vanzulli S; Piazzon I; Pasqualini CD; Bustuoabad OD; Ruggiero RA
Oncol Rep; 1999; 6(5):1073-84. PubMed ID: 10425305
[TBL] [Abstract][Full Text] [Related]
43. An interactive computer graphic system for 3-d stereoscopic reconstruction from serial sections: analysis of metastatic growth.
Chawla SD; Glass L; Freiwald S; Proctor JW
Comput Biol Med; 1982; 12(3):223-32. PubMed ID: 7172640
[TBL] [Abstract][Full Text] [Related]
44. Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.
Starkey JR; Davis WC; Talmadge JE
Cancer Immunol Immunother; 1982; 14(2):124-31. PubMed ID: 6965227
[TBL] [Abstract][Full Text] [Related]
45. Correlation between bizarre colony morphology and metastatic potential of tumor cells.
Cifone MA
Exp Cell Res; 1981 Feb; 131(2):435-41. PubMed ID: 7202546
[No Abstract] [Full Text] [Related]
46. Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma.
Chehrazi-Raffle A; Meza L; Alcantara M; Dizman N; Bergerot P; Salgia N; Hsu J; Ruel N; Salgia S; Malhotra J; Karczewska E; Kortylewski M; Pal S
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33688021
[TBL] [Abstract][Full Text] [Related]
47. Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model.
De Giovanni C; Nicoletti G; Landuzzi L; Palladini A; Lollini PL; Nanni P
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783695
[TBL] [Abstract][Full Text] [Related]
48. The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1alpha, IL-6, GM-CSF, and KC.
Smith CW; Chen Z; Dong G; Loukinova E; Pegram MY; Nicholas-Figueroa L; Van Waes C
Clin Exp Metastasis; 1998 Oct; 16(7):655-64. PubMed ID: 9932612
[TBL] [Abstract][Full Text] [Related]
49. Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or -6.
Takeda K; Fujii N; Nitta Y; Sakihara H; Nakayama K; Rikiishi H; Kumagai K
Jpn J Cancer Res; 1991 Nov; 82(11):1299-308. PubMed ID: 1752786
[TBL] [Abstract][Full Text] [Related]
50. [Tumor metastasis and growth factors].
Tsuruo T; Yamori T
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3374-8. PubMed ID: 2679395
[TBL] [Abstract][Full Text] [Related]
51. Are colony-stimulating factor-producing cells facilitated in the metastatic process?
Nicoletti G; Lollini PL; Bagnara GP; De Giovanni C; Del Re B; Bons L; Prodi G; Nanni P
Anticancer Res; 1987; 7(4B):695-700. PubMed ID: 3314670
[TBL] [Abstract][Full Text] [Related]
52. [A correlation between the abilities of tumor cells to produce GM-CSF and form metastasis].
Kumagai K; Hatakeyama K; Takeda K; Tsuchiya Y; Rikiishi H
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3367-73. PubMed ID: 2679394
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of tumor production of granulocyte-macrophage colony-stimulating factor by 1 alpha, 25-dihydroxyvitamin D3 reduces tumor motility and metastasis.
Young MR; Halpin J; Hussain R; Lozano Y; Djordjevic A; Devata S; Matthews JP; Wright MA
Invasion Metastasis; 1993; 13(4):169-77. PubMed ID: 8034438
[TBL] [Abstract][Full Text] [Related]
54. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
[TBL] [Abstract][Full Text] [Related]
55. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
